UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

MELLANOX TECHNOLOGIES, LTD.

(Exact Name of Registrant as Specified in Its Charter)

ISRAEL (State or Other Jurisdiction of Incorporation or Organization)		98-0233400 (I.R.S. Employer Identification No.)
HERMON BUILDING, YOKNEAM, ISRAEL (Address of Principal Executive Offices)		20692 (Zip Code)

Registrant’s Telephone Number, Including Area Code: +972-4-909-7200

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o		Accelerated filer þ		Non-accelerated filer o		Smaller reporting company o
				(Do not check if a smaller reporting company)

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No þ

     The total number of outstanding shares of the registrant’s Ordinary Shares, nominal value of NIS 0.0175 per share, as of October 29, 2010, was 33,961,865.

 

 

MELLANOX TECHNOLOGIES, LTD.

		Page No.
PART I
FINANCIAL INFORMATION
ITEM 1. Unaudited Condensed Consolidated Financial Statements			3
Unaudited Condensed Consolidated Balance Sheets — September 30, 2010 and December 31, 2009			3
Unaudited Condensed Consolidated Statements of Operations — Three and Nine Months Ended September 30, 2010 and 2009			4
Unaudited Condensed Consolidated Statements of Cash Flows — Nine Months Ended September 30, 2010 and 2009			5
Notes to Unaudited Condensed Consolidated Financial Statements			6
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			15
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk			22
ITEM 4. Controls and Procedures			23
PART II
OTHER INFORMATION
ITEM 1. Legal Proceedings			23
ITEM 1A. Risk Factors			23
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds			27
ITEM 3. Defaults Upon Senior Securities			27
ITEM 4. Removed and Reserved			27
ITEM 5. Other Information			27
ITEM 6. Exhibits			27
EX-31.1
EX-31.2
EX-32.1
EX-32.2

PART I. FINANCIAL INFORMATION

ITEM 1 — UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MELLANOX TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

		September 30,				December 31,
		2010				2009
		(In thousands)
ASSETS
Current assets:
Cash and cash equivalents		$	52,155			$	43,640
Short-term investments			187,392				166,357
Restricted cash			3,258				3,160
Accounts receivable, net			22,513				20,418
Inventories			12,215				9,328
Deferred taxes			4,452				8,605
Prepaid expenses and other			3,448				3,825
Total current assets			285,433				255,333
Property and equipment, net			15,063				9,734
Severance assets			5,348				4,629
Intangible assets, net			321				428
Deferred taxes			812				812
Other long-term assets			4,240				4,450
Total assets		$	311,217			$	275,386
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	10,297			$	8,775
Other accrued liabilities			14,615				14,804
Capital lease obligations, current			316				528
Total current liabilities			25,228				24,107
Accrued severance			6,822				5,778
Capital lease obligations			237				474
Other long-term obligations			2,813				2,144
Total liabilities			35,100				32,503
Commitments and contingencies (Note 5)
Shareholders’ equity:
Ordinary shares			139				135
Additional paid-in capital			259,646				240,807
Accumulated other comprehensive income			701				367
Retained earnings			15,631				1,574
Total shareholders’ equity			276,117				242,883
Total liabilities and shareholders’ equity		$	311,217			$	275,386

The accompanying notes are an integral part of these condensed consolidated financial statements.

MELLANOX TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2010				2009				2010				2009
		(In thousands, except per share data)
Total revenues		$	37,779			$	32,671			$	113,947			$	80,515
Cost of revenues			(9,861	)			(8,092	)			(29,073	)			(19,996	)
Gross profit			27,918				24,579				84,874				60,519
Operating expenses:
Research and development			14,973				10,944				41,245				29,686
Sales and marketing			5,445				4,273				15,867				12,011
General and administrative			2,675				2,633				8,060				6,800
Total operating expenses			23,093				17,850				65,172				48,497
Income from operations			4,825				6,729				19,702				12,022
Other income, net			55				126				217				864
Income before taxes on income			4,880				6,855				19,919				12,886
Provision for taxes on income			(1,377	)			(2,082	)			(5,862	)			(4,253	)
Net income		$	3,503			$	4,773			$	14,057			$	8,633
Net income per share — basic		$	0.10			$	0.15			$	0.42			$	0.27
Net income per share — diluted		$	0.10			$	0.14			$	0.40			$	0.26
Shares used in computing income per share:
Basic			33,787				32,113				33,438				31,969
Diluted			35,279				33,611				35,231				33,166

The accompanying notes are an integral part of these condensed consolidated financial statements.

MELLANOX TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

		Nine Months Ended
		September 30,
		2010				2009
		(In thousands)
Cash flows from operating activities:
Net income		$	14,057			$	8,633
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			4,073				3,117
Deferred income taxes			4,153				3,174
Share-based compensation expense			10,363				6,936
Gain on sale of investments			(485	)			(631	)
Excess tax benefit from share based compensation			(1,217	)			—
Impairment of investments			250				—
Changes in assets and liabilities:
Accounts receivable, net			(2,095	)			4,392
Inventories			(3,449	)			141
Prepaid expenses and other assets			1,140				441
Accounts payable			1,522				1,284
Accrued liabilities and other payables			2,814				(2,044	)
Net cash provided by operating activities			31,126				25,443
Cash flows from investing activities:
Purchase of severance-related insurance policies			(588	)			(646	)
Purchases of short-term investments			(182,615	)			(180,160	)
Proceeds from sales of short-term investments			122,726				100,997
Proceeds from maturities of short-term investments			39,265				9,580
Increase in restricted cash deposits			—				(884	)
Purchase of property and equipment			(9,295	)			(2,181	)
Purchase of equity investment in a private company			(135	)			—
Net cash used in investing activities			(30,642	)			(73,294	)
Cash flows from financing activities:
Principal payments on capital lease obligations			(449	)			(447	)
Proceeds from issuance of ordinary shares to employees			7,263				2,093
Excess tax benefit from share-based compensation			1,217				—
Net cash provided by financing activities			8,031				1,646
Net increase (decrease) in cash and cash equivalents			8,515				(46,205	)
Cash and cash equivalents at beginning of period			43,640				110,153
Cash and cash equivalents at end of period		$	52,155			$	63,948

The accompanying notes are an integral part of these condensed consolidated financial statements.

MELLANOX TECHNOLOGIES, LTD.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

     Company

     Mellanox Technologies, Ltd. (the “Company” or “Mellanox”) was incorporated in Israel and commenced operations in March 1999. Mellanox is a leading supplier of end-to-end connectivity solutions for data center servers and storage.

     Principles of presentation

     The condensed consolidated financial statements included in this quarterly report on Form 10-Q have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures contained in this quarterly report comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, for a quarterly report on Form 10-Q and are adequate to make the information presented not misleading. The condensed consolidated financial statements included herein reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the SEC on March 5, 2010. The results of operations for the nine months ended September 30, 2010 are not necessarily indicative of the results to be anticipated for the entire year ending December 31, 2010 or thereafter.

     Risks and uncertainties

     The Company is subject to all of the risks inherent in a company which operates in the dynamic and competitive semiconductor industry. Significant changes in any of the following areas could have a material adverse impact on the Company’s financial position and results of operations: unpredictable volume or timing of customer orders; ordered product mix; the sales outlook and purchasing patterns of the Company’s customers, based on consumer demands and general economic conditions; loss of one or more of the Company’s customers; decreases in the average selling prices of products or increases in the average cost of finished goods; the availability, pricing and timeliness of delivery of components used in the Company’s products; reliance on a limited number of subcontractors to manufacture, assemble, package and production test the Company’s products; the Company’s ability to successfully develop, introduce and sell new or enhanced products in a timely manner; product obsolescence and the Company’s ability to manage product transitions; and the timing of announcements or introductions of new products by the Company’s competitors.

     Additionally, the Company has a significant presence in Israel, including research and development activities, corporate facilities and sales support operations. Uncertainty surrounding the political, economic and military conditions in Israel may directly impact the Company’s financial results.

     Use of estimates

     The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenues and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to revenue recognition, allowances for doubtful accounts, sales returns and allowances, warranty reserves, inventory reserves, share-based compensation expense, long-term asset valuations, investments, deferred income tax asset valuation allowances, uncertain tax positions, litigation and other loss contingencies. These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not readily apparent from other sources. The actual results the

Company experiences may differ materially and adversely from its original estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.

     Significant accounting policies

     There have been no changes in the Company’s significant accounting policies that were disclosed in its Annual Report on Form 10-K for the fiscal year ended December 31, 2009.

     Concentration of credit risk

     The following table summarizes the revenues from customers (including original equipment manufacturers) in excess of 10% of the total revenues:

		Three Months Ended September 30,								Nine Months Ended September 30,
		2010				2009				2010				2009
Hewlett Packard			14	%			15	%			16	%			16	%
Dell			12	%			*				11	%			*
Supermicro Computer Inc.			12	%			*				*				11	%
IBM			*				14	%			*				10	%
Sun Microsystems			*				13	%			*				10	%
Fujitsu			*				11	%			*				*

     At September 30, 2010, Dell and Voltaire accounted for 13% and 11%, respectively, of the Company’s total accounts receivable. At December 31, 2009, IBM and Hewlett-Packard accounted for 21% and 13%, respectively, of the Company’s total accounts receivable.

     Product warranty

     Changes in the Company’s liability for product warranty during the nine months ended September 30, 2010 and 2009 are included in Other accrued liabilities and are as follows:

		Nine Months Ended
		September 30,
		2010				2009
		(In thousands)
Balance, beginning of the period		$	902			$	997
Warranties issued during the period			392				420
Reversal of warranty reserves			(217	)			(296	)
Settlements during the period			(268	)			(236	)
Balance, end of the period		$	809			$	885

     Net income per share

     The following table sets forth the computation of basic and diluted net income per share for the periods indicated:

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2010				2009				2010				2009
		(In thousands, except per share data)
Net income		$	3,503			$	4,773			$	14,057			$	8,633
Basic and diluted shares:
Weighted average ordinary shares outstanding used to compute basic net income per share			33,787				32,113				33,438				31,969
Effect of dilutive securities: stock awards			1,492				1,498				1,793				1,197
Shares used to compute diluted net income per share			35,279				33,611				35,231				33,166
Net income per share attributable to ordinary shareholders — basic		$	0.10			$	0.15			$	0.42			$	0.27
Net income per share attributable to ordinary shareholders — diluted		$	0.10			$	0.14			$	0.40			$	0.26

          The Company excluded outstanding options of 621,346 and 442,132, for the three months and nine months ended September 30, 2010, respectively, from the computation of diluted net income per common share, because including them would have had an anti-dilutive effect. The Company excluded outstanding options of 2.5 million and 3.9 million for the three and nine months ended September 30, 2009, respectively, from the computation of diluted net income per common share, because including them would have had an anti-dilutive effect. There were no anti-dilutive restricted stock units for the three and nine months ended September 30, 2010 and 2009, respectively.

     Recent accounting pronouncements

          With the exception of those stated below, there have been no recent accounting pronouncements or changes in accounting pronouncements during the nine months ended September 30, 2010, as compared to the recent accounting pronouncements described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, that are of material significance, or have potential material significance, to the Company.

          Effective April 1, 2009, the Company adopted the updated guidance related to subsequent events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. The updated guidance initially required the disclosure of the date through which an entity has evaluated subsequent events and the basis for that date — that is, whether that date represents the date the financial statements were issued or were available to be issued. However, in February 2010, the FASB amended the guidance to remove the requirement to disclose the date through which subsequent events were evaluated. Adoption of the updated guidance did not have a material impact on the Company’s consolidated results of operations or financial condition.

          Effective January 1, 2010, the Company adopted the FASB’s updated guidance related to fair value measurements and disclosures, which requires a reporting entity to disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and to describe the reasons for the transfers. In addition, in the reconciliation for fair value measurements using significant unobservable inputs, or Level 3, a reporting entity should disclose separately information about purchases, sales, issuances and settlements (that is, on a gross basis rather than one net number). The updated guidance also requires that an entity should provide fair value measurement disclosures for each class of assets and liabilities and disclosures about the valuation techniques and inputs used to measure fair value for both recurring and non-recurring fair value measurements for Level 2 and Level 3 fair value measurements. The guidance is effective for interim or annual financial reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward activity in Level 3 fair value measurements, which are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. The Company has updated its disclosures to comply with the updated guidance; however, adoption of the updated guidance did not have an impact on the Company’s consolidated results of operations or financial condition.

NOTE 2 — BALANCE SHEET COMPONENTS:

		September 30,				December 31,
		2010				2009
		(In thousands)
Cash and cash equivalents:
Cash		$	35,356			$	14,359
Money market funds			16,799				29,281
		$	52,155			$	43,640
Accounts receivable, net:
Accounts receivable		$	22,899			$	20,708
Less: Allowance for doubtful accounts			(386	)			(290	)
		$	22,513			$	20,418
Inventories:
Raw materials		$	1,005			$	941
Work-in-process			2,019				1,497
Finished goods			9,191				6,890
		$	12,215			$	9,328
Prepaid expense and other:
Prepaid expenses		$	1,590			$	1,648
Income tax and VAT receivable			621				949
Other receivable			581				949
Forward contracts			591				183

		September 30,				December 31,
		2010				2009
		(In thousands)
Other			65				96
		$	3,448			$	3,825
Property and equipment, net:
Computer equipment and software		$	36,210			$	28,175
Furniture and fixtures			1,902				1,809
Leasehold improvements			3,292				2,184
			41,404				32,168
Less: Accumulated depreciation and amortization			(26,341	)			(22,434	)
		$	15,063			$	9,734
Other long-term assets:
Equity investments in private companies		$	3,885			$	4,000
Prepaid expenses			241				387
Long term deposits			114				63
		$	4,240			$	4,450
Other accrued liabilities:
Payroll and related expenses		$	8,092			$	8,170
Professional services			3,148				3,169
Warranty			809				902
Income tax payable			27				683
Sales commissions			394				548
Deferred revenue			1,073				486
Other			1,072				846
		$	14,615			$	14,804
Other long-term obligations:
Income tax payable		$	1,761			$	1,510
Deferred revenue			549				—
Other			503				634
		$	2,813			$	2,144

NOTE 3 — INVESTMENTS AND FAIR VALUE MEASUREMENTS:

     Fair value hierarchy

     The Company measures its cash equivalents and marketable securities at fair value. The Company’s cash equivalents are classified within Level 1. Cash equivalents are valued primarily using quoted market prices utilizing market observable inputs. The Company’s investments in debt securities and certificates of deposits are classified within Level 2 as the market inputs to value these instruments consist of market yields, reported trades and broker/dealer quotes. In addition, foreign currency contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.

     The following table represents the fair value hierarchy of the Company’s financial assets measured at fair value as of September 30, 2010. There were no financial liabilities as of September 30, 2010.

		Level 1				Level 2				Level 3				Total
		(In thousands)
Money market funds		$	16,799			$	—			$	—			$	16,799
Certificates of deposit			—				41,608				—				41,608
U.S. Government bonds			—				7,033				—				7,033
Agency fixed rate securities			—				30,234				—				30,234
Agency discount notes			—				67,433				—				67,433
U.S. Treasury securities			—				41,084				—				41,084
Forward contracts			—				591				—				591
Total financial assets		$	16,799			$	187,983			$	—			$	204,782

     The following table represents the fair value hierarchy of the Company’s financial assets measured at fair value as of December 31, 2009. There were no financial liabilities as of December 31, 2009.

		Level 1				Level 2				Level 3				Total
		(In thousands)
Money market funds		$	29,281			$	—			$	—			$	29,281
U.S. Government bonds			—				5,746				—				5,746
Agency fixed rate securities			—				34,310				—				34,310
Agency discount notes			—				61,781				—				61,781
U.S. Treasury securities			—				64,520				—				64,520
Forward contracts			—				183				—				183
Total financial assets		$	29,281			$	166,540			$	—			$	195,821

     There were no transfers between Level 1 and Level 2 securities during the nine months ended September 30, 2010.

  Short-term investments

     At September 30, 2010 and December 31, 2009, the Company held short-term investments classified as available-for-sale securities as follows:

		September 30, 2010
						Gross
		Amortized				Unrealized				Estimated
		Cost				Gains				Fair Value
		(In thousands)
Money market funds		$	16,799			$	—			$	16,799
Certificates of deposits			41,608				—				41,608
U.S. Treasury and agency securities			145,674				110				145,784
Total investments in marketable securities			204,081				110				204,191
Less amounts classified as cash equivalents			(16,799	)			—				(16,799	)
		$	187,282			$	110			$	187,392

		December 31, 2009
						Gross
		Amortized				Unrealized				Estimated
		Cost				Gains				Fair Value
		(In thousands)
Money market funds		$	29,281			$	—			$	29,281
U.S. Treasury and agency securities			166,173				184				166,357
Total investments in marketable securities			195,454				184				195,638
Less amounts classified as cash equivalents			(29,281	)			—				(29,281	)
		$	166,173			$	184			$	166,357

     The contractual maturities of available-for-sale securities at September 30, 2010 are presented in the following table:

		September 30, 2010
		Amortized				Estimated
		Cost				Fair Value
		(In thousands)
Due in one year or less		$	175,280			$	175,382
Due between one and two years			12,002				12,010
Total investments in available-for-sale securities		$	187,282			$	187,392

     The contractual maturities of available-for-sale securities at December 31, 2009 were due in one year or less.

  Investments in privately-held companies:

     As of September 30, 2010, the Company’s investment portfolio included investments of $3.9 million in privately-held companies. The Company accounts for $3.5 million of these investments under the cost method. To determine if impairment exists, the Company monitors each portfolio company’s revenue and earnings trends relative to pre-defined milestones and overall business prospects, the

general market conditions in its industry and other factors related to its ability to remain in business, such as liquidity and receipt of additional funding.

     During the second quarter of 2010, the Company identified certain events and changes in circumstances indicating that the fair value of the investments in one of the portfolio companies had been negatively impacted and determined that the impairment of this investment was other than temporary. In determining whether a decline in value of its investment has occurred and is other than temporary, an assessment was made by considering available evidence, including the general market conditions in the portfolio company’s industry, its financial condition, near-term prospects and latest round of financing. The valuation also takes into account the portfolio company’s capital structure, liquidation preferences for its capital and other economic variables as well as other inputs that require management judgment. As a result of the assessment, the Company recorded a $250,000 impairment loss on this investment to reduce the carrying value to its estimated market value. The impairment loss is included in other income, net, on the Consolidated Statements of Operations for the nine months ended September 30, 2010. The carrying value of the Company’s investment was $0.4 million and is classified within other long term assets on the Company’s Consolidated Balance Sheets as of September 30, 2010.

NOTE 4 — DERIVATIVES AND HEDGING ACTIVITIES:

     The Company uses derivative instruments primarily to manage exposures to foreign currency. The Company enters into forward contracts to manage its exposure to changes in the exchange rate of the New Israeli Shekel (“NIS”) against the U.S. dollar. The Company’s primary objective in entering into these arrangements is to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The program is not designated for trading or speculative purposes. The Company’s forward contracts expose the Company to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. The Company seeks to mitigate such risk by limiting its counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.

     The Company uses forward contracts designated as cash flow hedges to hedge a substantial portion of future forecasted operating expenses in NIS. The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income (loss) (“OCI”) and subsequently reclassified into operating expenses in the same period in which the hedged operating expenses are recognized, or reclassified into other income, net, if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is de-designated because it is no longer probable of occurring or related to an ineffective portion of a hedge, as well as any amount excluded from the Company’s hedge effectiveness, is recognized as other income (expense) immediately. The net gains or losses relating to ineffectiveness were not material in the nine months ended September 30, 2010 and 2009. As of September 30, 2010, the Company had forward contracts in place that hedged future operating expenses of approximately 67.6 million NIS, or approximately $18.4 million based upon the exchange rate as of September 30, 2010. The forward contracts cover a substantial portion of future NIS denominated operating expenses expected to occur over the next twelve months.

     The Company does not use derivative financial instruments for purposes other than cash flow hedges.

  Fair value of derivative contracts

     Fair value of derivative contracts as of September 30, 2010 and December 31, 2009 were as follows:

		Derivative Assets Reported in								Derivative Liabilities Reported in
		Other Current Assets								Other Current Liabilities
		September 30,				December 31,				September 30,				December 31,
		2010				2009				2010				2009
		(In thousands)
Foreign exchange contracts designated as cash flow hedges		$	591			$	183			$	—			$	—
Total derivatives		$	591			$	183			$	—			$	—

  Effect of designated derivative contracts on accumulated other comprehensive income

     The following table represents the balance of designated derivative contracts as cash flow hedges as of September 30, 2010 and December 31, 2009, and their impact on OCI for the nine months ended September 30, 2010 (in thousands):

December 31, 2009		$	183
Amount of gain recognized in OCI (effective portion)			658
Amount of gain reclassified from OCI to income (effective portion)			(250	)
September 30, 2010		$	591

     Foreign exchange contracts designated as cash flow hedges relate primarily to operating expenses and the associated gains and losses are expected to be recorded in operating expenses when reclassed out of OCI. The Company expects to realize the accumulated OCI balance related to foreign exchange contracts within the next twelve months.

  Effect of derivative contracts on the condensed consolidated statement of operations

     The impact of derivative contracts on total operating expenses in the nine months ended September 30, 2010 and 2009 was as follows:

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2010				2009				2010				2009
		(In thousands)								(In thousands)
Gain (loss) on foreign exchange contracts designated as cash flow hedges		$	33			$	122			$	250			$	(717	)

NOTE 5 — COMMITMENTS AND CONTINGENCIES:

  Leases

     As of September 30, 2010, future minimum lease payments under non-cancelable operating and capital leases, and future minimum sublease rental receipts under non-cancelable operating leases are as follows:

		Capital				Operating
Year Ended December 31,		Leases				Leases
		(In thousands)
Remainder of 2010		$	86			$	1,284
2011			316				4,978
2012			158				2,415
2013			—				915
2014 and beyond			—				312
Total minimum lease payments and sublease income		$	560			$	9,904
Less: Amount representing interest			(7	)
Present value of capital lease obligations			553
Less: Current portion			(316	)
Long-term portion of capital lease obligations		$	237

     Service commitments

     At September 30, 2010, the Company had non-cancelable service commitments of $2.1 million, $1.0 million of which is expected to be paid within 2010 and $1.1 million in 2011 and beyond.

     Purchase commitments

     At September 30, 2010, the Company had non-cancelable purchase commitments of $8.9 million expected to be paid within one year. As of September 30, 2010, the Company had no non-cancelable purchase commitments with suppliers beyond one year.

NOTE 6 — SHAREHOLDERS’ EQUITY:

Comprehensive income

     The components of comprehensive income, net of taxes, are as follows:

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2010				2009				2010				2009
		(In thousands)
Net income		$	3,503			$	4,773			$	14,057			$	8,633
Other comprehensive income:
Change in unrealized gains on available-for-sale securities, net			6				(30	)			(74	)			(102	)
Change in unrealized gains on derivative contracts, net			1,084				366				408				711
Total comprehensive income		$	4,593			$	5,109			$	14,391			$	9,242

NOTE 7 — SHARE INCENTIVE PLANS:

  Stock option and restricted stock units activity

     The following tables summarize the activities under all equity incentive plans during the nine months ended September 30, 2010:

		Options Outstanding
						Weighted
		Number				Average				Weighted
		of				Exercise				Average
		Shares				Price				Fair Value
Outstanding at December 31, 2009			6,403,679			$	8.38			$	7.73
Options granted			494,000			$	21.21			$	12.24
Options exercised			(998,363	)		$	4.68			$	2.13
Options canceled			(216,787	)		$	11.99			$	6.03
Outstanding at September 30, 2010			5,682,529			$	10.06			$	6.65

     The weighted average fair value of options granted was $11.74 and $8.22 for the three months ended September 30, 2010 and 2009, respectively, and $12.24 and $7.65 for the nine months ended September 30, 2010 and 2009, respectively.

     The total pretax intrinsic value of options exercised in the nine months ended September 30, 2010 and 2009 was $17.2 million and $2.5 million, respectively. This intrinsic value represents the difference between the fair market value of the Company’s ordinary shares on the date of exercise and the exercise price of each option. Based on the closing price of the Company’s ordinary shares of $19.64 on September 30, 2010, the total pretax intrinsic value of all outstanding options was $55.3 million. As of September 30, 2010, options to buy 3,039,069 shares were exercisable, out of which options to buy 3,034,415 shares were fully vested and options to buy 4,654 shares were unvested but exercisable. The total pretax intrinsic value of exercisable options at September 30, 2010 was $34.8 million.

     Effective January 2010, the Company began granting restricted stock units under the Global Share Incentive Plan. Restricted stock units represent a right to receive ordinary shares of the Company at a future vesting date with no cash payment from the holder. In general, restricted stock units vest over four years from the grant date.

     Restricted stock units activity in the nine months ended September 30, 2010 is set forth below:

		Restricted Stock Units Outstanding
						Weighted
		Number				Average
		of				Grant Date
		Shares				Fair Value
Non vested restricted stock units at December 31, 2009			—			$	—
Restricted stock units granted			437,008				19.93
Restricted stock units vested			(6,668	)			22.54
Restricted stock units canceled			(9,547	)			19.89
Non vested restricted stock units at September 30, 2010			420,793			$	19.89

     There were no restricted stock units granted in the three months ended September 30, 2010. The weighted average fair value of restricted stock units granted in the nine months ended September 30, 2010 was $19.93.

     The total intrinsic value of all outstanding restricted stock units was $8.3 million as of September 30, 2010.

     The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of September 30, 2010:

		Number
		of
		Shares
Stock options outstanding			5,682,529
Restricted stock units			420,793
Stock authorized for future issuance			1,116,236
ESPP shares available for future issuance			114,302
Total shares reserved for future issuance as of September 30, 2010			7,333,860

     Share-based compensation

     The following weighted average assumptions are used to value stock options and ESPP granted in connection with the Company’s equity incentive plans for the nine months ended September 30, 2010 and 2009:

		Employee Share								Employee Share
		Options								Purchase Plan
		Nine Months Ended September 30,								Nine Months Ended September 30,
		2010				2009				2010				2009
Dividend yield, %			—				—				—				—
Expected volatility, %			60.0				63.3				54.7				57.7
Risk free interest rate, %			2.15				2.53				0.10				0.10
Expected life, years			6.25				6.19				0.53				0.53
Estimated forfeiture rate, %			8.66				8.46				—				—

     The following table summarizes the distribution of total share-based compensation expense in the consolidated statements of operations:

		Three months ended								Nine months ended
		September 30,								September 30,
		2010				2009				2010				2009
		(In thousands)
Cost of goods sold		$	96			$	64			$	284			$	199
Research and development			2,091				1,378				5,925				4,200
Sales and marketing			642				528				1,895				1,405
General and administrative			724				413				2,259				1,131
Total share-based compensation expense		$	3,553			$	2,383			$	10,363			$	6,935

     At September 30, 2010, there was $28.4 million of total unrecognized share-based compensation costs related to non-vested share-based compensation arrangements. The costs are expected to be recognized over a weighted average period of 2.34 years.

NOTE 8 — INCOME TAXES:

     As of September 30, 2010 and December 31, 2009, the Company had unrecognized tax benefits of $1,672,000 and $1,442,000, respectively. It is the Company’s policy to classify accrued interest and penalties as part of the unrecognized tax benefits, or tax contingencies, and record the expense in the provision for income taxes. As of September 30, 2010, the amount of accrued interest and penalties totaled $100,000. As of September 30, 2010, calendar years 2004 through 2009 were open and subject to potential examination in one or more jurisdictions. The Company’s U.S. subsidiary is currently under examination by the Internal Revenue Service for fiscal year 2008 related to income tax and for fiscal years 2008 and 2009 related to employment tax.

     The Company’s effective tax rate is highly dependent upon the geographic distribution of its worldwide earnings or losses, tax regulations and tax holiday benefits in Israel, and the effectiveness of the Company’s tax planning strategies. The Company’s effective tax rates were 28.2% and 29.4% for the three and nine months ended September 30, 2010, respectively and 30.4% and 33.0% for the three and nine months ended September 30, 2009, respectively. The difference between the Company’s effective tax rates and the 35% federal statutory rate resulted primarily from non-tax-deductible expenses such as share-based compensation expense and the accrual of unrecognized tax benefits, and interest and penalties associated with unrecognized tax positions, partially offset by foreign earnings taxed at rates lower than the federal statutory rate. The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous and the Company is required to make many subjective assumptions and judgments regarding its income tax exposures. In addition, interpretations of and guidance surrounding income tax laws and regulations are subject to change over time. Any changes in the Company’s subjective assumptions and judgments could materially affect amounts recognized in its consolidated balance sheets and statements of income.

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     The following discussion and analysis of our financial condition as of September 30, 2010 and results of operations for the three and nine months ended September 30, 2010 and September 30, 2009 should be read together with our financial statements and related notes included elsewhere in this report. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those set forth under the section entitled “Risk Factors” in Part II, Item 1A of this report. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. All forward-looking statements included in this report are based on information available to us on the date of this report, and we assume no obligation to update any forward-looking statements contained in this report. Quarterly financial results may not be indicative of the financial results of future periods.

Overview

       General

     We are a leading fabless semiconductor company that produces and supplies high-performance connectivity products which facilitate efficient data transmission between servers, communications infrastructure equipment and storage systems. We design, develop and market adapter, gateway and switch ICs, all of which are silicon devices that provide high performance connectivity. We also offer a complete line of adapter cards that incorporate our adapter ICs, and switch and gateway system product lines that incorporate our switch and gateway ICs. Our end-to-end products, including adapter, gateway and switch ICs, adapter cards, switch systems, gateway systems and cables are an integral part of a total networking solution focused on computing, storage and communication applications used in enterprise data centers, high-performance computing and embedded systems. We are one of the pioneers of InfiniBand; an industry-standard architecture that provides specifications for high-performance interconnects. We believe we are the leading supplier of field-proven InfiniBand-compliant semiconductor products that deliver industry-leading performance and capabilities, which is demonstrated by the performance, efficiency and scalability of clustered computing and storage systems that incorporate our products. In addition to supporting InfiniBand, our products also support the industry standard Ethernet interconnect specification and provide unique product differentiation and connectivity flexibility.

     Our adapters provide bandwidth up to 10Gb/s (Single Data Rate or SDR) Ethernet or InfiniBand, 20Gb/s (Double Data Rate or DDR) InfiniBand and 40Gb/s (Quad Data Rate or QDR) InfiniBand and our switch ICs provide bandwidth up to 120Gb/s per interface. Our switch systems based on our switch ICs range in port size and density from top-of-rack 36-port switches through director-class 648-port switches.

     We have been shipping our InfiniBand products since 2001 and our Ethernet products since 2007. During 2008 we introduced Virtual Protocol Interconnect, or VPI, into our adapter ICs and cards. VPI provides the ability for an adapter to automatically sense whether a communications port is connected to an Ethernet fabric or an InfiniBand fabric. Data centers which use VPI adapters in their servers have the ability to dynamically select the connectivity protocol for use by those servers. In addition to reselling our adapter cards, one of our major OEM customers has begun to embed our ConnectX VPI Ethernet and InfiniBand silicon devices directly on the motherboard of multiple server and server blade products. This will increase the proliferation of our IB and Ethernet solutions in the market. Over time, we expect that other major OEMs will similarly embed our high-speed interconnect products due to the market demand for higher I/O throughput and performance.

     We have established significant expertise with high-performance interconnect solutions from successfully developing and implementing multiple generations of our products. Our expertise enables us to develop and deliver products that serve as building blocks for creating reliable and scalable InfiniBand and Ethernet solutions with leading performance.

     Revenues. We derive revenues from sales of our ICs, cards, switch systems and accessories primarily to leading server, storage and communication infrastructure OEM customers. The sales of our products are made worldwide through multiple channels, including direct sales force, our network of domestic and international sales representatives and independent distributors. Revenues were approximately $113.9 million for the nine months ended September 30, 2010, compared to approximately $80.5 million for the nine months ended September 30, 2009, representing an increase of approximately 41.5%. To date, we have derived a substantial portion of our revenues from a relatively small number of customers. Total sales to customers representing more than 10% of revenues accounted for 27% and 47% of our total revenues for the nine months ended September 30, 2010 and 2009, respectively. The loss of one or more of our principal customers, the reduction or deferral of purchases, or changes in the mix of our products ordered by any one of these customers could cause our revenues to decline materially if we are unable to increase our revenues from other customers.

     Cost of revenues and gross profit. The cost of revenues consists primarily of the cost of silicon wafers purchased from our foundry supplier, Taiwan Semiconductor Manufacturing Company, or TSMC, costs associated with the assembly, packaging and production testing of our products by Advanced Semiconductor Engineering, or ASE, outside processing costs associated with the manufacture of our host channel adapters, or HCA cards, and switch systems by Flextronics and Comtel, royalties due to third parties, warranty costs, excess and obsolete inventory costs and costs of personnel associated with production management and quality assurance. In addition, after we purchase wafers from our foundries, we also face yield risk related to manufacturing these wafers into semiconductor devices. Manufacturing yield is the percentage of acceptable product resulting from the manufacturing process, as identified when the product is tested as a finished IC. If our manufacturing yields decrease, our cost per unit increases, which could have a significant adverse impact on our cost of revenues. We do not have long-term pricing agreements with TSMC and ASE. Accordingly, our costs are subject to price fluctuations based on the overall cyclical demand for semiconductors.

     We purchase our inventory pursuant to standard purchase orders. We estimate that lead times for delivery of our finished semiconductors from our foundry supplier and assembly, packaging and production testing subcontractor are approximately three to four months, lead times for delivery from our HCA card manufacturing subcontractor are approximately eight to ten weeks, and lead times for delivery from our switch systems manufacturing subcontractors are approximately twelve weeks. We build inventory based on forecasts of customer orders rather than the actual orders themselves. In addition, our customers are seeking opportunities to minimize their inventory on hand while demanding shorter lead times for orders placed. As a result, we have increased our inventory levels over the past three quarters to meet this demand.

     We expect our cost of revenues to increase over time as a result of the expected increase in our sales volume. We expect our cost of revenues as a percentage of sales to increase in the future as a result of a reduction in the average sale price of our products and a higher percentage of revenue deriving from sales of HCA cards, switch systems and cables, which generally yield lower gross margins. This trend will depend on overall customer demand for our products, our product mix, competitive product offerings and related pricing and on our ability to reduce manufacturing costs.

     Operational Expenses

     Research and Development Expenses. Our research and development expenses consist primarily of salaries, share-based compensation and associated costs for employees engaged in research and development, costs associated with computer aided design software tools, depreciation expense, outsourcing expenses, tape out costs and qualification expenses. Tape out costs are expenses related to the manufacture of new products, including charges for mask sets, prototype wafers, mask set revisions and testing incurred before releasing new products to the market. We anticipate our research and development expenses will increase in future periods based on an increase in personnel to support our product development activities and the introduction of new products. These expenses may fluctuate over the course of a year based on the timing of our scheduled product tape outs.

     Sales and Marketing Expenses. Sales and marketing expenses consist primarily of salaries, share-based compensation and associated costs for employees engaged in sales, marketing and customer support, commission payments to external, third party sales representatives, advertising, and charges for trade shows, promotions and travel. We expect these expenses will increase in absolute dollars in future periods based on an increase in sales and marketing personnel, increased marketing activities and higher commission payments related to increased revenues.

     General and Administrative Expenses. General and administrative expenses consist primarily of salaries, share-based compensation and associated costs for employees engaged in finance, human resources and administrative activities, and other professional services expenses for accounting and corporate legal fees. We expect these expenses will increase in absolute dollars in future periods based on an increase in personnel to support our business activities.

     Taxes on Income. Our operations in Israel have been granted “Approved Enterprise” status by the Investment Center of the Israeli Ministry of Industry, Trade and Labor, which makes us eligible for tax benefits under the Israeli Law for Encouragement of Capital Investments, 1959. Under the terms of the Approved Enterprise program, income that is attributable to our operations in Yokneam, Israel will be exempt from income tax for a period of ten years commencing when we first generate taxable income after setting off our losses from prior years. Income that is attributable to our operations in Tel Aviv, Israel will be exempt from income tax for a period of two years commencing when we first generate taxable income and will be subject to a reduced income tax rate (generally 10-25%, depending on the percentage of foreign investment in the Company) for the following five to eight years. We expect the Approved Enterprise Tax Holiday associated with our Yokneam and Tel Aviv operations to begin in 2011. The Yokneam Tax Holiday is expected to expire in 2020 and the Tel Aviv Tax Holiday is expected to expire between 2015 and 2018.

     In connection with the commencement of the Approved Enterprise Tax Holiday in 2011, all deferred tax assets associated with our Yokneam and Tel-Aviv operations will be remeasured at a 0% rate. We expect that approximately $3.7M will need to be recognized as tax expense during the fourth quarter of 2010 due to this remeasurement.

Critical Accounting Policies and Estimates

     Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

     We believe that the assumptions and estimates associated with revenue recognition, allowance for doubtful accounts, inventory valuation, warranty provision, income taxes and share-based compensation have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. For further information on all of our significant accounting policies, please see Note 1 of the accompanying notes to our consolidated financial statements.

     See our Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 5, 2010, for a discussion of additional critical accounting policies and estimates. We believe there have been no significant changes in our critical accounting policies as compared to what was previously disclosed in the Form 10-K for the year ended December 31, 2009.

Results of Operations

     The following table sets forth our consolidated statements of operations as a percentage of revenues for the periods indicated:

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2010				2009				2010				2009
Total revenues			100	%			100	%			100	%			100	%
Cost of revenues			(26	)			(25	)			(26	)			(25	)
Gross profit			74				75				74				75
Operating expenses:
Research and development			40				33				36				37
Sales and marketing			14				13				14				15
General and administrative			7				8				7				8
Total operating expenses			61				54				57				60
Income from operations			13				21				17				15
Other income, net			0				0				0				1
Provision for taxes on income			(4	)			(6	)			(5	)			(5	)
Net income			9	%			15	%			12	%			11	%

Comparison of the Three Months Ended September 30, 2010 to the Three Months Ended September 30, 2009

     The following table represents our total revenues for the three months ended September 30, 2010 and 2009 by product type.

		Three Months Ended September 30,
						%of								%of
		2010				Revenues				2009				Revenues
		(In thousands)								(In thousands)
ICs & boards		$	29,337				78			$	29,151				89
Switch systems			5,438				14				1,716				5
Cables, accessories and other			3,004				8				1,804				6
Total revenue		$	37,779				100			$	32,671				100

     Revenues. Revenues were $37.8 million for the three months ended September 30, 2010 compared to $32.7 million for the three months ended September 30, 2009, representing an increase of approximately 16%. The increase was primarily attributable to higher switch system revenues. We expect our switch system revenues to continue to increase as we provide more end-to-end solutions. Revenues for the three months ended September 30, 2010 are not necessarily indicative of future results.

     Gross Profit and Margin. Gross profit was $27.9 million for the three months ended September 30, 2010 compared to $24.6 million for the three months ended September 30, 2009, representing an increase of approximately 14%. As a percentage of revenues, gross margin decreased to 73.9% in the three months ended September 30, 2010 from 75.2% in the three months ended September 30, 2009. The decrease in gross margins, as a percentage of revenues, was primarily due to the increase in sales of our switch systems, cables and accessories, which typically yield lower gross margins. Gross margin for the three months ended September 30, 2010 is not necessarily indicative of future results.

     Research and Development. Research and development expenses were $15.0 million in the three months ended September 30, 2010 compared to $10.9 million in the three months ended September 30, 2009, representing an increase of approximately 37%. The increase consisted of $2.5 million in employee related expenses primarily due to headcount additions and merit increases, $861,000 in facilities and maintenance associated with additional office space in Israel, $712,000 in share-based compensation expenses related to new share-based awards, $287,000 in depreciation expenses, $240,000 in outsourcing expenses due to additional support required for an upcoming tape out and software support, and $208,000 in software and equipment related expenses, partially offset by a decrease of $772,000 in new product expenses. We expect that research and development expense will increase in absolute dollars in future periods as we continue to devote additional resources to develop new products, meet the changing requirements of our customers, and expand into new markets and technologies.

     For a further discussion of share-based compensation included in research and development expense, see “Share-based Compensation Expense” below.

     Sales and Marketing. Sales and marketing expenses were $5.4 million for the three months ended September 30, 2010 compared to $4.3 million for the three months ended September 30, 2009, representing an increase of approximately 27%. The increase consisted of $663,000 in employee related expenses primarily due to headcount additions and merit increases, $168,000 in sales and marketing activities, $162,000 in expenses related to design work, educational research and freight, and $114,000 in share-based compensation expenses primarily related to new share-based awards. The increases were partially offset by a decrease of $179,000 in external sales representative compensation associated with changes in our external sales representative compensation plan.

     For a further discussion of share-based compensation included in sales and marketing expense, see “Share-based Compensation Expense” below.

     General and Administrative. General and administrative expenses were $2.7 million for the three months ended September 30, 2010 compared to $2.6 million for the three months ended September 30, 2009, representing an increase of approximately 2%. The increase consisted of $311,000 in share-based compensation expense primarily due to new share-based awards, $293,000 in employee related expenses associated with to headcount additions and merit increases, and $109,000 in HR related expenses related to training and special events, partially offset by decreases in professional services of $743,000.

     For a further discussion of share-based compensation included in general and administrative expense, see “Share-based Compensation Expense” below.

     Other Income, Net. Other income, net consists of interest earned on cash and cash equivalents and short-term investments, and foreign currency exchange gains and losses. Other income, net was approximately $55,000 for the three months ended September 30, 2010 compared to approximately $126,000 for the three months ended September 30, 2009. The decrease consisted of $98,000 of foreign currency exchange losses partially offset by an increase of $15,000 in interest income associated with higher average interest rates paid on investments.

     Provision for Taxes on Income. Provision for taxes on income was $1.4 million for the three months ended September 30, 2010 compared to $2.1 million for the three months ended September 30, 2009. The effective tax rate was 28.2% and 30.4% for the three months ended September 30, 2010 and 2009, respectively. The difference between our effective tax rates and the 35% federal statutory rate resulted primarily from non-tax-deductible expenses such as share-based compensation expense and the accrual of unrecognized tax benefits, and interest and penalties associated with unrecognized tax positions, partially offset by profits earned in Israel, where the tax rate is lower than the U.S. tax rate.

Comparison of the Nine Months Ended September 30, 2010 to the Nine Months Ended September 30, 2009

     The following table represents our total revenues for the nine months ended September 30, 2010 and 2009 by product type.

		Nine Months Ended September 30,
						%of								%of
		2010				Revenues				2009				Revenues
		(In thousands)								(In thousands)
ICs & boards		$	92,999				82			$	69,475				86
Switch systems			13,125				11				7,331				9
Cables, accessories and other			7,823				7				3,709				5
Total revenue		$	113,947				100			$	80,515				100

     Revenues. Revenues were $113.9 million for the nine months ended September 30, 2010 compared to $80.5 million for the nine months ended September 30, 2009, representing an increase of approximately 42%. Our revenues were impacted by unfavorable economic conditions during the nine months ended September 30, 2009. The increase in revenues during the nine months ended September 30, 2010 was attributed to expanded adoption of our products in different market segments. Revenues for the nine months ended September 30, 2010 are not necessarily indicative of future results.

     Gross Profit and Margin. Gross profit was approximately $84.9 million for the nine months ended September 30, 2010 and $60.5 million for the nine months ended September 30, 2009 representing an increase of approximately 40%. As a percentage of revenues, gross margin decreased to 74.5% in the nine months ended September 30, 2010 from 75.2% in the nine months ended September 30, 2009. The decline in gross margins as a percentage of revenues was primarily due to changes in our product mix. As a percentage of revenues, we experienced increases in our switch system, cable and accessories revenues, for which we typically earn lower gross margins. Gross margin for the nine months ended September 30, 2010 is not necessarily indicative of future results.

     Research and Development. Research and development expenses were $41.2 million in the nine months ended September 30, 2010 compared to approximately $29.7 million in the nine months ended September 30, 2009, representing an increase of approximately 39%. The increase consisted of $7.7 million in employee related expenses primarily due to headcount additions and merit increases, an increase in share-based compensation expenses of $1.7 million associated with new share-based awards, an increase in facilities and maintenance of $1.5 million related to additional office space in Israel, an increase in software and equipment related expenses of $998,000, and an increase of $488,000 in outsourcing expenses, partially offset by a decrease in new product expenses of $1.4 million primarily due to product design costs associated with a tape out during the nine months ended September 30, 2009.

     For a further discussion of share-based compensation included in research and development expense, see “Share-based Compensation Expense” below.

     Sales and Marketing. Sales and marketing expenses were $15.9 million for the nine months ended September 30, 2010 compared to approximately $12.0 million for the nine months ended September 30, 2009, representing an increase of approximately 32%. The increase consisted of $2.5 million in employee related expenses primarily due to headcount additions and merit increases, an increase in share-based compensation of $490,000 associated with to new share-based awards, an increase in sales and marketing activities of $255,000, an increase in equipment expenses of $207,000 related to evaluation equipment, and an increase in travel related expenses

of $184,000, partially offset by a decrease of $381,000 in commission expenses due to changes in our external sales representative compensation plan.

     For a further discussion of share-based compensation included in sales and marketing expense, see “Share-based Compensation Expense” below.

     General and Administrative. General and administrative expenses were approximately $8.1 million for the nine months ended September 30, 2010 compared to approximately $6.8 million for the nine months ended September 30, 2009, representing an increase of approximately 19%. The increase was due to higher share-based compensation expenses of $1.1 million related to share-based awards, an increase in employee related expenses of $703,000 associated with headcount additions and merit increases, and an increase in HR related expenses of $303,000 related to training and special events, partially offset by a decrease in professional services of $971,000 associated with legal and accounting fees.

     For a further discussion of share-based compensation included in general and administrative expense, see “Share-based Compensation Expense” below.

     Share-based compensation expense. The following table presents details of total share-based compensation expense that is included in each functional line item in our consolidated statements of operations:

		Three months ended								Nine months ended
		September 30,								September 30,
		2010				2009				2010				2009
		(In thousands)
Cost of goods sold		$	96			$	63			$	284			$	199
Research and development			2,091				1,378				5,925				4,200
Sales and marketing			642				528				1,895				1,405
General and administrative			724				413				2,259				1,131
Total share-based compensation expense		$	3,553			$	2,382			$	10,363			$	6,935

     At September 30, 2010, there was $28.4 million of total unrecognized share-based compensation costs related to non-vested share-based compensation arrangements. The costs are expected to be recognized over a weighted average period of 2.34 years.

     Other Income, Net. Other income, net consists of interest earned on cash and cash equivalents and foreign currency exchange gains and losses. Other income, net was approximately $217,000 for the nine months ended September 30, 2010 compared to approximately $864,000 for the nine months ended September 30, 2009, representing a decrease of approximately 75%. The decrease consisted primarily of lower interest income of $256,000, an impairment of an investment in a privately held company of $250,000 and foreign exchange losses of $193,000.

     Provision for Taxes on Income. Provision for taxes on income was approximately $5.9 million for the nine months ended September 30, 2010 compared to approximately $4.3 million for the nine months ended September 30, 2009. Our effective tax rates were 29.4% and 33.0% for the nine months ended September 30, 2010 and 2009, respectively. The difference between our effective tax rates and the 35% federal statutory rate resulted primarily from non-tax-deductible expenses such as stock-based compensation expense and the accrual of unrecognized tax benefits, interest and penalties associated with unrecognized tax positions, partially offset by profits earned in Israel, where the tax rate is lower than the U.S. tax rate.

Liquidity and Capital Resources

     Since our inception, we have financed our operations through a combination of sales of equity securities and cash generated by operations. As of September 30, 2010, our principal source of liquidity consisted of cash and cash equivalents of $52.2 million and short-term investments of $187.4 million. We expect that our current cash and cash equivalents and short-term investments and our cash flows from operating activities will be sufficient to fund our operations over the next twelve months after taking into account potential business and technology acquisitions, if any, and expected increases in research and development expenses, including tape out costs, higher sales and marketing expenses, general and administrative expenses and capital expenditures to support our infrastructure and growth.

     Operating activities

     Net cash provided by our operating activities amounted to $31.1 million and $25.4 million in the nine months ended September 30, 2010 and 2009, respectively. Net cash provided by operating activities in the nine months ended September 30, 2010 was primarily attributable to net income of $14.1 million and net non-cash items of $17.1 million, partially offset by changes in assets and liabilities of $68,000. Changes in assets and liabilities resulted from an increase in accrued liabilities and other payables of $2.8 million, an increase in accounts payable of $1.5 million, and a decrease in prepaid expenses of $1.1 million, partially offset by an increase in inventory of $3.4 million due to higher safety stock levels and an increase in accounts receivable of approximately $2.1 million due to the timing of sales during the period.

     Net cash provided by operating activities of approximately $25.4 million in the nine months ended September 30, 2009 was primarily attributable to net income of approximately $8.6 million and non-cash items of $12.6 million, partially offset by changes in assets and liabilities of $4.2 million. Changes in assets and liabilities resulted from a decrease in accounts receivable of approximately $4.4 million associated with improved collections and an increase in accounts payable of approximately $1.3 million, partially offset by a decrease of approximately $2.0 million in accrued liabilities and other payables due to a reduction in payroll related liabilities.

     Investing activities

     Net cash used in investing activities was approximately $30.6 million in the nine months ended September 30, 2010 and was primarily attributable to net purchases of short term investments of $20.6 million and purchases of property and equipment of $9.3 million. Net cash used in investing activities was approximately $73.3 million in the nine months ended September 30, 2009 and was primarily attributable to the net purchases of short term investments of $69.6 million, purchases of property and equipment of $2.1 million and an increase in restricted cash of $884,000.

     Financing activities

     Our financing activities generated $8.0 million in the nine months ended September 30, 2010 and were primarily due to proceeds from stock option exercises and purchases pursuant to our employee stock purchase plan of $7.3 million and excess tax benefits from share-based compensation of $1.2 million, partially offset by principal payments on capital lease obligations of $449,000. In the nine months ended September 30, 2009, our financing activities provided approximately $1.6 million primarily due to proceeds from stock option exercises and purchases pursuant to our employee stock purchase plan of $2.1 million, partially offset by principal payments on capital lease obligations of $447,000.

Off-Balance Sheet Arrangements

     As of September 30, 2010, we did not have any off-balance sheet arrangements.

Contractual Obligations

     The following table summarizes our contractual obligations at September 30, 2010, and the effect those obligations are expected to have on our liquidity and cash flows in future periods:

						Payments Due by Period
						Less Than								Beyond
		Total				1 Year				1-3 Years				3 Years
		(In thousands)
Commitments under capital lease		$	560			$	323			$	237			$	—
Non-cancelable operating lease commitments			9,904				4,767				4,637				500
Service commitments			2,071				1,300				746				25
Purchase commitments			8,897				8,897				—				—
Total		$	21,432			$	15,287			$	5,620			$	525

     For purposes of this table, purchase obligations for the purchase of goods or services are defined as agreements that are enforceable and legally binding and that specify all significant terms including: fixed or minimum purchase quantities; fixed, minimum or variable price provisions; and the approximate timing of the transaction. Our purchase orders are based on our current manufacturing needs and are fulfilled by our vendors within short time horizons. We do not have significant agreements for the purchase of raw materials or other goods specifying minimum quantities or set prices that exceed our expected requirements.

Contingencies

     As of September 30, 2010, our unrecognized tax benefits totaled approximately $1.7 million, which would reduce our income tax expense and effective tax rate, if recognized. Due to the uncertainty with respect to the timing of future cash flows associated with our unrecognized tax benefits as of September 30, 2010, we are unable to make any reasonably reliable estimates of the periods of cash settlements with the relevant taxing authorities.

Recent Accounting Standards

     With the exception of those stated below, there have been no recent accounting pronouncements or changes in accounting pronouncements during the nine months ended September 30, 2010, as compared to the recent accounting pronouncements described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, that are of material significance, or have potential material significance, to us.

     Effective April 1, 2009, we adopted the updated guidance related to subsequent events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. The updated guidance initially required the disclosure of the date through which an entity has evaluated subsequent events and the basis for that date — that is, whether that date represents the date the financial statements were issued or were available to be issued. However, in February 2010, the FASB amended the guidance to remove the requirement to disclose the date through which subsequent events were evaluated. Adoption of the updated guidance did not have a material impact on our consolidated results of operations or financial condition.

     Effective January 1, 2010, we adopted the FASB’s updated guidance related to fair value measurements and disclosures, which requires a reporting entity to disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and to describe the reasons for the transfers. In addition, in the reconciliation for fair value measurements using significant unobservable inputs, or Level 3, a reporting entity should disclose separately information about purchases, sales, issuances and settlements (that is, on a gross basis rather than one net number). The updated guidance also requires that an entity should provide fair value measurement disclosures for each class of assets and liabilities and disclosures about the valuation techniques and inputs used to measure fair value for both recurring and non-recurring fair value measurements for Level 2 and Level 3 fair value measurements. The guidance is effective for interim or annual financial reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward activity in Level 3 fair value measurements, which are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. Therefore, we have not yet adopted the guidance with respect to the roll forward activity in Level 3 fair value measurements. We updated our disclosures to comply with the updated guidance; however, adoption of the updated guidance did not have an impact on our consolidated results of operations or financial condition.

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Fluctuation Risk

     We do not have any long-term borrowings. Our investments consist of cash and cash equivalents, short-term deposits, money market funds and interest bearing investments in U.S. government debt securities with an average maturity of less than one year. The primary objective of our investment activities is to preserve principal while maximizing income without significantly increasing risk. By policy we limit the amount of our credit exposure through diversification and restricting our investments to highly rated securities. Individual securities are limited to comprising no more than 10% of the portfolio value at the time of purchase, except U.S Treasury or Agency securities. Highly rated securities are defined as having a minimum Moody or Standard & Poor’s rating of A2 or A, respectively. We have not experienced any material losses on cash equivalents or short-term investments. We do not enter into investments for trading or speculative purposes. Our investments are exposed to market risk due to a fluctuation in interest rates, which may affect our interest income and the fair market value of our investments. Due to the short-term nature of our investment portfolio, we do not believe an immediate 2% change in interest rates would have a material effect on the fair market value of our portfolio, and therefore we do not expect our operating results or cash flows to be materially affected by a sudden change in market interest rates.

Foreign Currency Exchange Risk

     We derive all of our revenues in U.S. dollars. The U.S. dollar is our functional and reporting currency in all of our foreign locations. However, a significant portion of our headcount related expenses, consisting principally of salaries and related personnel

expenses and our Israeli facility expenses are denominated in new Israeli shekels, or NIS. This foreign currency exposure gives rise to market risk associated with exchange rate movements of the U.S. dollar against the NIS. Furthermore, we anticipate that a material portion of our expenses will continue to be denominated in NIS. To the extent the U.S. dollar weakens against the NIS, we will experience a negative impact on our profits.

     To protect against reductions in the value and the volatility of future cash flows caused by changes in foreign currency exchange rates, we have established a balance sheet and anticipated transaction risk management program. Currency forward contracts and natural hedges are generally utilized in this hedging program. We do not enter into forward contracts for trading or speculative purposes. Our hedging program reduces, but does not eliminate, the impact of currency exchange rate movements (see Part II, Item 1A, “Risk Factors”). If we were to experience a 10% change in currency exchange rates, the impact on assets and liabilities denominated in currencies other than the U.S. dollar, after taking into account hedges and offsetting positions, would result in a loss before taxes of approximately $110,000 at September 30, 2010. There would also be an impact on future operating expenses denominated in currencies other than the U.S. dollar. At September 30, 2010, approximately $3.6 million of our monthly operating expenses were denominated in NIS. As of September 30, 2010, we had forward contracts in place that hedged future operating expenses of approximately 67.6 million NIS, or approximately $18.4 million based upon the exchange rate as of September 30, 2010. The forward contracts cover a significant portion of future NIS denominated operating expenses expected to occur over the next twelve months. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. However, under current market conditions, failure of one or more of these financial institutions is possible and could result in incurred losses.

ITEM 4 — CONTROLS AND PROCEDURES

     We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

     As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on the foregoing, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

     There has been no change in our internal control over financial reporting during our most recent quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1 — LEGAL PROCEEDINGS

     We are not currently party to any material legal proceedings.

ITEM 1A — RISK FACTORS

     Investing in our ordinary shares involves a high degree of risk. You should carefully consider the following risk factors, in addition to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2009, the other information set forth in this report and our other filings with the SEC, before purchasing our ordinary shares. Each of these risk factors could harm our business, financial condition or operating results, as well as decrease the value of an investment in our ordinary shares.

     There have been no material changes from risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2009, except for the following:

Risks Related to Our Business

We depend on a small number of customers for a significant portion of our sales, and the loss of any one of these customers will adversely affect our revenues.

     A small number of customers account for a significant portion of our revenues. For the three months ended September 30, 2010, sales to Hewlett-Packard, Dell and Super Micro Computer Inc. accounted for 14%, 12% and 12%, respectively, of our total revenues, while sales to our top ten customers accounted for 71% of our revenues. For the year ended December 31, 2009, sales to Hewlett-Packard, IBM and Super Micro Computer Inc. accounted for 15%, 11% and 10%, respectively, of our total revenues, while sales to our top ten customers accounted for 79% of our revenues. Because the majority of servers, storage, communications infrastructure equipment and embedded systems are sold by a relatively small number of vendors, we expect that we will continue to depend on a small number of customers to account for a significant percentage of our revenues for the foreseeable future. Our customers, including our most significant customers, are not obligated by long-term contracts to purchase our products and may cancel orders with limited potential penalties. If any of our large customers reduces or cancels its purchases from us for any reason, it could have an adverse effect on our revenues and results of operations.

We may not obtain sufficient patent protection on the technology embodied in our products, which could harm our competitive position and increase our expenses.

     Our success and ability to compete in the future may depend to a significant degree upon obtaining sufficient patent protection for our proprietary technology. As of September 30, 2010, we had 22 issued patents and 33 patent applications pending in the United States, 5 issued patents in Taiwan, and 2 patent applications pending and 3 patents issued in Israel, each of which covers aspects of the technology in our products. Patents that we currently own do not cover all of the products that we presently sell. Our patent applications may not result in issued patents, and even if they result in issued patents, the patents may not have claims of the scope we seek. Even in the event that these patents are not issued, the applications may become publicly available and proprietary information disclosed in the applications will become available to others. In addition, any issued patents may be challenged, invalidated or declared unenforceable. The term of any issued patent in the United States would be 20 years from its filing date, and if our applications are pending for a long time period, we may have a correspondingly shorter term for any patent that may be issued. Our present and future patents may provide only limited protection for our technology and may not be sufficient to provide competitive advantages to us. For example, competitors could be successful in challenging any issued patents or, alternatively, could develop similar or more advantageous technologies on their own or design around our patents. Also, patent protection in certain foreign countries may not be available or may be limited in scope and any patents obtained may not be as readily enforceable as in the United States and Israel, making it difficult for us to effectively protect our intellectual property from misuse or infringement by other companies in these countries. Our inability to obtain and enforce our intellectual property rights in some countries may harm our business. In addition, given the costs of obtaining patent protection, we may choose not to protect certain innovations that later turn out to be important.

Indemnity obligations pursuant to various agreements expose us to potentially substantial liability for intellectual property infringement, damages related to our products and technologies and other claims.

     In the normal course of business, we enter into agreements and terms and conditions that require us to indemnify the other party against third-party claims alleging that one of our products infringes or misappropriates intellectual property rights, as well as against certain claims relating to property damage, personal injury or acts or omissions relating to supplied products or technologies, or acts or omissions made by us or our employees, agents or representatives. In addition, we are obligated pursuant to indemnification undertakings with our officers and directors to indemnify them to the fullest extent permitted by law for claims and expenses related to acts or omissions made by our directors and officers in their capacities as such. If we receive demands for indemnification under these agreements and terms and conditions, they will likely be very expensive to settle or defend, and we may incur substantial legal fees in connection with any indemnity demands. Our indemnification obligations under these agreements and terms and conditions may be unlimited in duration and amount, and could have an adverse effect on our business, financial condition and results of operations.

     See the risk factor in our Annual Report on Form 10-K for the year ended December 31, 2009 entitled “Intellectual property litigation, which is common in our industry, could be costly, harm our reputation, limit our ability to sell our products and divert the attention of management and technical personnel” for a further discussion of this risk factor.

Risks Related to Operations in Israel and Other Foreign Countries

Regional instability in Israel may adversely affect business conditions and may disrupt our operations and negatively affect our revenues and profitability.

     We have engineering facilities and corporate and sales support operations and, as of September 30, 2010, we had 345 full-time and 58 part-time employees located in Israel. A significant amount of our assets is located in Israel. Accordingly, political, economic and military conditions in Israel may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors, as well as incidents of civil unrest. During the winter of 2008 and the summer of 2006, Israel was engaged in armed conflicts with Hamas and Hezbollah. These conflicts involved missile strikes against civilian targets in southern and northern Israel, and negatively affected business conditions in Israel. In addition, Israel and companies doing business with Israel have, in the past, been the subject of an economic boycott. Although Israel has entered into various agreements with Egypt, Jordan and the Palestinian Authority, Israel has been and is subject to civil unrest and terrorist activity, with varying levels of severity, since September 2000. Any future armed conflicts or political instability in the region may negatively affect business conditions and adversely affect our results of operations. Parties with whom we do business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when necessary. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in the agreements.

     We can give no assurance that security and political conditions will have no impact on our business in the future. Hostilities involving Israel or the interruption or curtailment of trade between Israel and its present trading partners could adversely affect our operations and could make it more difficult for us to raise capital. While we did not sustain damages from the recent conflicts with Hamas and Hezbollah referred to above, a large portion of our Israeli operations, which are located in northern Israel, are within range of Hezbollah missiles and we or our immediate surroundings may sustain damages in a missile attack, which could adversely affect our operations.

     In addition, our business insurance does not cover losses that may occur as a result of events associated with the security situation in the Middle East. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained. Any losses or damages incurred by us could have a material adverse effect on our business.

     We are susceptible to additional risks from our international operations.

     We derived 56% and 63% of our revenues in the nine months ended September 30, 2010 and 2009, respectively, from sales outside of North America. As a result, we face additional risks from doing business internationally, including:

	•		reduced protection of intellectual property rights in some countries;
	•		difficulties in staffing and managing foreign operations;
	•		longer sales and payment cycles;
	•		greater difficulties in collecting accounts receivable;
	•		adverse economic conditions;
	•		seasonal reductions in business activity;
	•		potentially adverse tax consequences;
	•		laws and business practices favoring local competition;
	•		costs and difficulties of customizing products for foreign countries;
	•		compliance with a wide variety of complex foreign laws and treaties;
	•		compliance with the United States’ Foreign Corrupt Practices Act and similar anti-bribery laws in other jurisdictions;

	•		compliance with export control and regulations;
	•		licenses, tariffs, other trade barriers, transit restrictions and other regulatory or contractual limitations on our ability to sell or develop our products in certain foreign markets;
	•		foreign currency exchange risks;
	•		fluctuations in freight rates and transportation disruptions;
	•		political and economic instability;
	•		variance and unexpected changes in local laws and regulations;
	•		natural disasters and public health emergencies; and
	•		trade and travel restrictions.

     Our principal research and development facilities are located in Israel, and our directors, executive officers and other key employees are located primarily in Israel and the United States. In addition, we engage sales representatives in various countries throughout the world to market and sell our products in those countries and surrounding regions. If we encounter any of the above risks in our international operations, we could experience slower than expected revenue growth and our business could be harmed.

Exchange rate fluctuations between the U.S. dollar and the NIS may negatively affect our earnings.

     Although all of our revenues and a majority of our expenses are denominated in U.S. dollars, a significant portion of our research and development expenses and our Israeli facility expenses are incurred in new Israeli shekels, or NIS. As a result, we are exposed to risk to the extent that the inflation rate in Israel exceeds the rate of devaluation of the NIS in relation to the U.S. dollar, or if the timing of these devaluations lags behind inflation in Israel. In that event, the U.S. dollar cost of our research and development operations in Israel will increase and our U.S. dollar-measured results of operations will be adversely affected. To the extent that the value of the NIS increases against the U.S. dollar, our expenses on a U.S. dollar cost basis increase. We cannot predict any future trends in the rate of inflation in Israel or the rate of appreciation of the NIS against the U.S. dollar. The Israeli rate of inflation amounted to 3.4%, 3.8% and 3.9% for the years ended December 31, 2007, 2008 and 2009, respectively, and to 1.9% and 3.4% for the nine months ended September 30, 2010 and 2009, respectively. The increase in value of the NIS against the U.S. dollar amounted to 8.9%, 1.1% and 0.7% in the years ended December 31, 2007, 2008 and 2009, respectively. In the nine months ended September 30, 2010 and September 30, 2009, the increase in the value of the NIS against the U.S. dollar amounted to 2.9% and 1.2%, respectively. If the U.S. dollar cost of our research and development operations and facility expenses in Israel increases, our dollar-measured results of operations will be adversely affected. Our operations also could be adversely affected if we are unable to guard against currency fluctuations in the future. Further, because all of our international revenues are denominated in U.S. dollars, a strengthening of the dollar versus other currencies could make our products less competitive in foreign markets and collection of receivables more difficult. To help manage this risk we have been engaged in foreign currency hedging activities. These measures, however, may not adequately protect us from material adverse effects due to the impact of inflation in Israel and changes in value of NIS against the U.S. dollar.

Risks Related to Our Ordinary Shares

The ownership of our ordinary shares will continue to be highly concentrated, and your interests may conflict with the interests of our existing shareholders.

     Our executive officers and directors and their affiliates, together with our current significant shareholders, beneficially owned approximately 37% of our outstanding ordinary shares as of September 30, 2010. Moreover, based on information filed with SEC or reported to us, four of our shareholders, Fidelity Management and Research, Delek Group, Migdal Insurance and Financial Holdings and Psagot Investment House, combined beneficially owned approximately 29% of our outstanding ordinary shares as of September 30, 2010. Accordingly, these shareholders, acting as a group, have significant influence over the outcome of corporate actions requiring shareholder approval, including the election of directors, any merger, consolidation or sale of all or substantially all of our assets or any other significant corporate transaction. These shareholders could delay or prevent a change of control of our company,

even if such a change of control would benefit our other shareholders. The significant concentration of share ownership may adversely affect the trading price of our ordinary shares due to investors’ perception that conflicts of interest may exist or arise.

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

     None.

ITEM 3 — DEFAULTS UPON SENIOR SECURITIES

     Not applicable.

ITEM 4 — REMOVED AND RESERVED

ITEM 5 — OTHER INFORMATION

     None.

ITEM 6 — EXHIBITS

3.1 (1)		Amended and Restated Articles of Association of Mellanox Technologies, Ltd. (as amended on May 18, 2008).
4.1 (2)		Amended and Restated Investor Rights Agreement dated as of October 9, 2001, by and among Mellanox Technologies, Ltd., purchasers of Series A Preferred Shares, Series B Preferred Shares and Series D Redeemable Preferred Shares who are signatories to such agreement and certain holders of Ordinary Shares who are signatories to such agreement, and for purposes of certain sections thereof, the holder of Series C Preferred Shares issued or issuable pursuant to the Series C Preferred Share Purchase Agreement dated November 5, 2000.
4.2 (3)		Amendment to the Amended and Restated Investor Rights Agreement dated as of February 2, 2007, by and among Mellanox Technologies, Ltd., purchasers of Series A Preferred Shares, Series B Preferred Shares and Series D Redeemable Preferred Shares who are signatories to such agreement and certain holders of Ordinary Shares who are signatories to such agreement, and for purposes of certain sections thereof, the holder of Series C Preferred Shares issued or issuable pursuant to the Series C Preferred Share Purchase Agreement dated November 5, 2000.
31.1		Certification of the Company’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of the Company’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of the Company’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of the Company’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 4, 2010		Mellanox Technologies, Ltd.
		/s/ Michael Gray
		Michael Gray
		Chief Financial Officer
		(Duly Authorized Officer and Principal Financial Officer)

Exhibit Index

3.1 (1)		Amended and Restated Articles of Association of Mellanox Technologies, Ltd. (as amended on May 18, 2008).
4.1 (2)		Amended and Restated Investor Rights Agreement dated as of October 9, 2001, by and among Mellanox Technologies, Ltd., purchasers of Series A Preferred Shares, Series B Preferred Shares and Series D Redeemable Preferred Shares who are signatories to such agreement and certain holders of Ordinary Shares who are signatories to such agreement, and for purposes of certain sections thereof, the holder of Series C Preferred Shares issued or issuable pursuant to the Series C Preferred Share Purchase Agreement dated November 5, 2000.
4.2 (3)		Amendment to the Amended and Restated Investor Rights Agreement dated as of February 2, 2007, by and among Mellanox Technologies, Ltd., purchasers of Series A Preferred Shares, Series B Preferred Shares and Series D Redeemable Preferred Shares who are signatories to such agreement and certain holders of Ordinary Shares who are signatories to such agreement, and for purposes of certain sections thereof, the holder of Series C Preferred Shares issued or issuable pursuant to the Series C Preferred Share Purchase Agreement dated November 5, 2000.
31.1		Certification of the Company’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of the Company’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of the Company’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of the Company’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.